On Friday 05/24/2024 the closing price of the Becton, Dickinson & Co. (BD) share was $230.30 on BTT.
Compared to the opening price on Friday 05/24/2024 on BTT of $234.45, this is a drop of 1.80%.
Becton, Dickinson & Co. (BD)'s market capitalization is $67.96 B by 289.01 M shares outstanding.
Is Becton, Dickinson stock a Buy, Sell or Hold?
Becton, Dickinson stock has received a consensus rating of buy. The average rating score is and is based on 24 buy ratings, 5 hold ratings, and 1 sell ratings.What was the 52-week low for Becton, Dickinson stock?
The low in the last 52 weeks of Becton, Dickinson stock was 228.15. According to the current price, Becton, Dickinson is 100.28% away from the 52-week low.What was the 52-week high for Becton, Dickinson stock?
The high in the last 52 weeks of Becton, Dickinson stock was 286.45. According to the current price, Becton, Dickinson is 79.87% away from the 52-week high.What are analysts forecasts for Becton, Dickinson stock?
The 30 analysts offering price forecasts for Becton, Dickinson have a median target of 283.07, with a high estimate of 319.00 and a low estimate of 235.00. The median estimate represents a 80.83 difference from the last price of 228.79.Becton, Dickinson Stock Snapshot
228.66
Bid
100.00
Bid Size
228.81
Ask
7.00
Ask Size
5/24/2024
Date
3:59 PM
Time
49,241.00
Volume
230.30
Prev. Close
230.60
Open
67.96 B
Market Cap
289.01 M
Number of Shares
228.15
Day Low
230.86
Day High
228.79
228.15
52 Week Low
286.45
52 Week High
228.79
3.78
Dividend
1.65
Dividend Yield
21.17
P/E Ratio
99.86
Free Float in %
13.04
EPS 2024
89.56
Book Value per Share
15.88
Cash Flow per Share
Becton, Dickinson News More News
Historical Prices for Becton, Dickinson
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Becton, Dickinson Analyst Data
Total Analysts: 30
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 235.00
Median: 283.07
Highest: 319.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Becton, Dickinson Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
05/06/24 | Barclays Capital | Maintained Buy | $312 | |||
02/05/24 | Barclays Capital | Maintained Buy | $305 | |||
01/03/24 | Raymond James Financial, Inc. | Maintained Buy | $275 | |||
12/04/23 | Morgan Stanley | Maintained Buy | $280 | |||
11/10/23 | Piper Sandler | Maintained Buy | $280 | |||
11/10/23 | Raymond James Financial, Inc. | Maintained Buy | $269 | |||
08/21/23 | Citigroup Corp. | Maintained Hold | $282 | |||
08/07/23 | Barclays Capital | Maintained Buy | $303 | |||
08/04/23 | Morgan Stanley | Maintained Buy | $310 | |||
08/04/23 | Raymond James Financial, Inc. | Maintained Buy | $304 | |||
07/24/23 | Piper Sandler | Maintained Buy | $305 | |||
07/24/23 | Raymond James Financial, Inc. | Upgraded to Buy | $305 | |||
05/30/23 | Morgan Stanley | Maintained Buy | $295 | |||
05/08/23 | Citigroup Corp. | Maintained Hold | $260 | |||
05/08/23 | Barclays Capital | Maintained Buy | $284 | |||
05/05/23 | Piper Sandler | Upgraded to Buy | $290 | |||
04/04/23 | Evercore | Maintained Buy | $275 | |||
02/03/23 | Morgan Stanley | Maintained Buy | $295 | |||
02/03/23 | Piper Sandler | Maintained Hold | $260 | |||
01/06/23 | Morgan Stanley | Maintained Buy | $290 | |||
01/03/23 | Bank of America Merrill Lynch | Upgraded to Buy | $290 | |||
12/12/22 | Citigroup Corp. | Upgraded to Hold | $250 | |||
11/23/22 | Goldman Sachs | Maintained Buy | $272 | |||
11/11/22 | Piper Sandler | Maintained Hold | $245 | |||
10/11/22 | Morgan Stanley | Maintained Buy | $275 | |||
08/16/22 | Goldman Sachs | Maintained Buy | $319 | |||
07/18/22 | Stifel, Nicolaus & Co., Inc. | Maintained Buy | $280 | |||
07/15/22 | Morgan Stanley | Maintained Buy | $272 | |||
07/11/22 | Citigroup Corp. | Downgraded to Sell | $235 | |||
06/24/22 | Wells Fargo & Co | Upgraded to Buy | $275 |
Becton, Dickinson Estimates* in USD
2024 | 2025 | 2026 | 2027 | 2028 | |
---|---|---|---|---|---|
Revenue | 20,242 | 21,402 | 22,602 | 23,464 | 24,690 |
Dividend | 3.78 | 3.84 | 2.72 | - | - |
Dividend Yield (in %) | 1.64 % | 1.67 % | 1.18 % | - | - |
EPS | 13.04 | 14.24 | 15.61 | 16.88 | 17.90 |
P/E Ratio | 17.66 | 16.17 | 14.75 | 13.65 | 12.87 |
EBIT | 4,883 | 5,309 | 5,752 | 6,182 | 6,666 |
EBITDA | 5,761 | 6,532 | 7,014 | 7,683 | 8,302 |
Net Profit | 3,793 | 4,147 | 4,553 | 4,846 | 5,258 |
Net Profit Adjusted | 3,793 | 4,147 | 4,553 | 4,846 | 5,258 |
Pre-Tax Profit | 4,398 | 4,853 | 5,315 | 5,702 | 6,186 |
Net Profit (Adjusted) | 3,663 | 4,103 | 4,220 | - | - |
EPS (Non-GAAP) ex. SOE | 12.95 | 14.49 | 15.77 | - | - |
EPS (GAAP) | 8.64 | 9.46 | 12.27 | - | - |
Gross Income | 10,787 | 11,532 | 12,185 | 12,644 | 13,330 |
Cash Flow from Investing | -1,282 | -1,309 | -1,337 | - | - |
Cash Flow from Operations | 3,834 | 4,306 | 4,707 | - | - |
Cash Flow from Financing | -2,206 | -2,379 | -2,985 | - | - |
Cash Flow per Share | 15.88 | 18.21 | 14.89 | - | - |
Free Cash Flow | 2,973 | 3,866 | 4,216 | - | - |
Free Cash Flow per Share | - | - | - | - | - |
Book Value per Share | 89.56 | 92.98 | 97.73 | - | - |
Net Debt | 13,017 | 10,738 | 8,053 | - | - |
Research & Development Exp. | 1,152 | 1,212 | 1,263 | 1,212 | 1,263 |
Capital Expenditure | 905 | 936 | 968 | - | - |
Selling, General & Admin. Exp. | 4,780 | 5,002 | 5,162 | 5,251 | 5,401 |
Shareholder’s Equity | 25,379 | 25,172 | 25,329 | - | - |
Total Assets | 51,795 | 51,363 | 50,715 | - | - |
Previous Quarter |
Current Quarter ending 06/30/24 |
Next Quarter ending 09/30/24 |
Current Year ending 09/30/24 |
Next Year ending 09/30/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | - | 13 | 13 | 13 | 13 |
Average Estimate | - | 3.309 USD | 3.888 USD | 13.044 USD | 14.240 USD |
Year Ago | - | 2.960 USD | 3.420 USD | 12.210 USD | 13.044 USD |
Publish Date | - | 5/2/2024 | 8/1/2024 | - | - |
Revenue Estimates | |||||
No. of Analysts | - | 11 | 11 | 13 | 13 |
Average Estimate | - | 5,076 USD | 5,402 USD | 20,242 USD | 21,402 USD |
Year Ago | - | 4,878 USD | 5,087 USD | 19,372 USD | 20,242 USD |
Publish Date | - | 5/2/2024 | 8/1/2024 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Sales | 12,093 | 15,983 | 17,290 | 17,117 | 20,248 | 18,870 | 19,372 |
Change of sales in % | -3.12 | 32.17 | 8.18 | -1.00 | 18.29 | -6.81 | 2.66 |
Gross profit on sales | 5,942 | 7,262 | 8,288 | 7,577 | 9,476 | 8,477 | 8,170 |
Gross profit on sales change in % | -0.82 | 22.21 | 14.13 | -8.58 | 25.06 | -10.54 | -3.62 |
Operating income | 2,169 | 2,241 | 2,894 | 2,156 | 3,270 | 2,512 | 2,196 |
Operating income change in % | 0.51 | 3.32 | 29.14 | -25.50 | 51.67 | -23.18 | -12.58 |
Income before tax | 976 | 1,173 | 1,176 | 985 | 2,242 | 1,783 | 1,662 |
Income before tax change in % | -9.12 | 20.18 | 0.26 | -16.24 | 127.61 | -20.47 | -6.79 |
Income after tax | 1,100 | 311 | 1,234 | 874 | 2,092 | 1,779 | 1,484 |
Income after tax change in % | 12.70 | -71.73 | 296.78 | -29.17 | 139.36 | -14.96 | -16.58 |
Balance Sheet
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Total liabilities | 24,786 | 32,910 | 30,684 | 30,247 | 30,189 | 27,652 | 26,983 |
Total liabilities change in % | 94.08 | 95.79 | 92.55 | 84.17 | 82.83 | 70.02 | 70.05 |
Equity | 12,948 | 20,994 | 21,081 | 23,765 | 23,677 | 25,282 | 25,797 |
Equity change in % | 69.61 | 62.15 | 0.41 | 12.73 | -0.37 | 6.78 | 2.05 |
Balance sheet total | 37,734 | 53,904 | 51,765 | 54,012 | 53,866 | 52,934 | 52,780 |
Balance sheet total change in % | 47.48 | 42.85 | -3.97 | 4.34 | -0.27 | -1.73 | -0.29 |
Key Data
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|
Sales per share | 54.09 | 60.40 | 62.92 | 60.61 | 69.32 | 65.67 | 67.17 |
P/E ratio (year end quote, basic EPS) | 42.54 | 435.00 | 64.20 | 85.67 | 35.86 | 37.91 | 52.36 |
P/E ratio (ear end quote, diluted EPS) | 42.54 | 435.00 | 64.20 | 85.67 | 35.86 | 37.91 | 52.36 |
P/E ratio (year end quote) | 42.54 | 435.00 | 64.20 | 85.67 | 35.86 | 37.91 | 52.36 |
Dividend yield in % | 1.49 | 1.15 | 1.22 | 1.36 | 1.35 | 1.56 | 1.41 |
Equity ratio in % | 34.31 | 38.94 | 40.72 | 44.00 | 43.95 | 47.76 | 48.88 |
Debt ratio in % | 65.69 | 61.05 | 59.28 | 56.00 | 56.04 | 52.24 | 51.12 |
Becton, Dickinson Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Goette Roland | 05/14/2024 | 800.00 | 13,808.00 | 235.29 | Sell | No |
Goette Roland | 05/14/2024 | 1,100.00 | 11,308.00 | 237.46 | Sell | No |
Goette Roland | 05/14/2024 | 1,400.00 | 12,408.00 | 236.99 | Sell | No |
Goette Roland | 05/12/2024 | 28.00 | 14,608.00 | 237.90 | Sell | No |
Goette Roland | 05/12/2024 | 1,572.00 | 14,636.00 | 237.14 | Sell | No |
Goette Roland | 05/12/2024 | 1,700.00 | 16,208.00 | 236.28 | Sell | No |
Garrison Michael David | 04/29/2024 | 1,715.00 | 5,381.00 | 232.81 | Sell | No |
Neal Shana Carol | 04/03/2024 | 1,921.00 | 16,389.00 | n/a | Sell | No |
Spoerel Thomas J | 03/13/2024 | 282.00 | 2,276.00 | 238.29 | Sell | No |
Garrison Michael David | 02/29/2024 | 178.00 | 7,096.00 | n/a | Sell | No |
Spoerel Thomas J | 02/29/2024 | 36.00 | 2,558.00 | n/a | Sell | No |
Ezell Antoine C | 02/29/2024 | 282.00 | 9,320.00 | n/a | Sell | No |
BURZIK CATHERINE M | 01/22/2024 | 900.00 | 13,242.00 | n/a | Buy | No |
RING TIMOTHY M | 01/22/2024 | 900.00 | 56,890.00 | n/a | Buy | No |
Byington Carrie L | 01/22/2024 | 900.00 | 2,855.00 | n/a | Buy | No |
Waldstreicher Joanne | 01/22/2024 | 900.00 | 1,323.00 | n/a | Buy | No |
Jones Christopher Ian Montague | 01/22/2024 | 900.00 | 21,405.00 | n/a | Buy | No |
Henderson Jeffrey William | 01/22/2024 | 900.00 | 5,568.00 | n/a | Buy | No |
ECKERT R ANDREW | 01/22/2024 | 900.00 | 8,124.00 | n/a | Buy | No |
Brown William M | 01/22/2024 | 900.00 | 2,512.00 | n/a | Buy | No |
Fraser Claire | 01/22/2024 | 900.00 | 22,696.00 | n/a | Buy | No |
SCOTT BERTRAM L | 01/22/2024 | 900.00 | 35,197.00 | n/a | Buy | No |
Shan David | 01/02/2024 | 44.00 | 5,693.00 | n/a | Sell | No |
Garrison Michael David | 12/10/2023 | 1,239.00 | 7,274.00 | 232.46 | Sell | No |
Byrd Richard | 11/27/2023 | 2,156.00 | 4,120.00 | 238.47 | Sell | No |
Becton, Dickinson Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | Becton, Dickinson & Co. (BD) | 3.64 | 1.41 | USD |
2022 | Becton, Dickinson & Co. (BD) | 3.48 | 1.56 | USD |
2021 | Becton, Dickinson & Co. (BD) | 3.32 | 1.35 | USD |
2020 | Becton, Dickinson & Co. (BD) | 3.16 | 1.36 | USD |
2019 | Becton, Dickinson & Co. (BD) | 3.08 | 1.22 | USD |
2018 | Becton, Dickinson & Co. (BD) | 3.00 | 1.15 | USD |
2017 | Becton, Dickinson & Co. (BD) | 2.92 | 1.49 | USD |
2016 | Becton, Dickinson & Co. (BD) | 2.64 | 1.47 | USD |
2015 | Becton, Dickinson & Co. (BD) | 2.40 | 1.81 | USD |
2014 | Becton, Dickinson & Co. (BD) | 2.18 | 1.92 | USD |
2013 | Becton, Dickinson & Co. (BD) | 1.98 | 1.98 | USD |
2012 | Becton, Dickinson & Co. (BD) | 1.80 | 2.29 | USD |
2011 | Becton, Dickinson & Co. (BD) | 1.64 | 2.24 | USD |
2010 | Becton, Dickinson & Co. (BD) | 1.48 | 2.00 | USD |
2009 | Becton, Dickinson & Co. (BD) | 1.32 | 1.89 | USD |
2008 | Becton, Dickinson & Co. (BD) | 1.14 | 1.42 | USD |
2007 | Becton, Dickinson & Co. (BD) | 0.98 | 1.19 | USD |
2006 | Becton, Dickinson & Co. (BD) | 0.86 | 1.19 | USD |
2005 | Becton, Dickinson & Co. (BD) | 0.72 | 1.37 | USD |
2004 | Becton, Dickinson & Co. (BD) | 0.60 | 1.16 | USD |
2003 | Becton, Dickinson & Co. (BD) | 0.40 | 1.11 | USD |
2002 | Becton, Dickinson & Co. (BD) | 0.39 | 1.37 | USD |
2001 | Becton, Dickinson & Co. (BD) | 0.38 | 1.03 | USD |
2000 | Becton, Dickinson & Co. (BD) | 0.37 | 1.40 | USD |
1999 | Becton, Dickinson & Co. (BD) | 0.34 | 1.21 | USD |
*Yield of the Respective Date
Becton, Dickinson & Co. (BD) Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 3.888 USD | Q3 2024 Earnings Release | 08/01/2024 |
Earnings Report | - | Q4 2024 Earnings Release | 11/07/2024 |
Earnings Report | - | Q1 2025 Earnings Release | 01/30/2025 |
Earnings Report | - | Q2 2025 Earnings Release | 05/01/2025 |
Becton, Dickinson & Co. (BD) Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 2.680 USD | Q2 2024 Earnings Release | 05/02/2024 |
Press Conference | - | - | 05/02/2024 |
Press Conference | - | - | 11/09/2023 |
Press Conference | - | - | 08/03/2023 |
Becton, Dickinson Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S.
Moody’s Daily Credit Risk Score
Becton, Dickinson Shareholder
Owner | in % |
---|---|
Freefloat | 99.86 |
The Vanguard Group, Inc. | 9.04 |
Vanguard Group, Inc. (Subfiler) | 8.63 |
State Street Corp. | 4.68 |
T. Rowe Price Associates, Inc. (Investment Management) | 3.60 |
T Rowe Price Associates, Inc. (13F Subfiler) | 3.34 |
Vanguard Total Stock Market ETF | 3.15 |
BlackRock Fund Advisors | 2.89 |
T. Rowe Price Investment Management, Inc. | 2.60 |
Vanguard 500 Index Fund | 2.54 |
Morgan Stanley Investment Management Ltd. | 2.34 |
BlackRock Institutional Trust Co. NA | 2.19 |
Geode Capital Management LLC | 2.09 |
T Rowe Price Capital Appreciation Fund | 1.69 |
Massachusetts Financial Services Co. | 1.67 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Becton, Dickinson Management
Name | Job |
---|---|
Thomas E. Polen | Chairman, President & Chief Executive Officer |
Thomas J. Spoerel | Chief Accounting Officer, Senior VP & Controller |
Ebonee Lewis | Chief Employment Counsel |
Claudia Curtis | Chief Ethics & Compliance Officer, Senior VP |
Christopher J. DelOrefice | Chief Financial Officer & Executive Vice President |
Denise Russell Fleming | Chief Information Officer & EVP-Technology |
Rishi Grover | Chief Integrated Supply Chain Officer & EVP |
Antoine Ezell | Chief Marketing Officer & EVP-North America |
Ronald P. Silverman | Chief Medical Officer & Executive Vice President |
Shana Carol Neal | Chief People Officer & Executive Vice President |
Ami E. Simunovich | Chief Quality & Regulatory Officer, Executive VP |
David Shan | Chief Quality Officer & Executive Vice President |
Stephen O. Richard | Chief Risk Officer & Senior Vice President |
Joseph M. Smith | Chief Scientific Officer & Senior Vice President |
Vishy Kanda | Chief Strategy Officer & Senior Vice President |
Elizabeth McCombs | Chief Technology Officer & Executive VP |
David Hickey | Executive VP & President-Life Sciences Segment |
Michelle Quinn | Executive Vice President & General Counsel |
Carrie L. Byington | Independent Director |
Catherine M. Burzik | Independent Director |
Christopher Ian Montague Jones | Independent Director |
Claire M. Fraser-Liggett | Independent Director |
Jeffrey William Henderson | Independent Director |
Joanne Waldstreicher | Independent Director |
Robert Andrew Eckert | Independent Director |
Timothy M. Ring | Independent Director |
William M. Brown | Independent Director |
Bertram L. Scott | Lead Independent Director |
Gary M. Cohen | President-Global Health & Executive VP |
Brooke Story | President-Integrated Diagnostic Solutions |
Gary Michael DeFazio | Secretary, Senior VP & Associate General Counsel |
Antoinette F. Segreto | Senior Vice President-Taxes |
Gregory Rodetis | Treasurer, Senior VP & Head-Investor Relations |